Danish biotech scores DKK 149 million from four investors
Four Danish and international investors, including Novo Seeds and Arix Bioscience, have backed the pre-clinical work of Aarhus-based biotech company Stipe Therapeutics to the tune of DKK 149 million (USD 21.9 million).
The Aarhus-based biotech company Stipe Therapeutics has come so far in its pre-clinical development that four investors have invested 20 million euros (around DKK 149 million) to support the company’s work in developing new immune therapies against cancer.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Bioinnovation Institute opens with massive expectations
For abonnenter
